Related Experiment Video
Updated: May 24, 2026
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Periodontitis Among Adults With Osteoarthritis: A Target Trial
Ignacio Leiva-Escobar1, Aiswarya Puzhakkara Chennas1, Zoheir Alayash1
1Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.
Background:
Nonsteroidal anti-inflammatory drugs (NSAIDs) may mitigate periodontal tissue breakdown through cyclooxygenase (COX) inhibition; however, their long-term effects on the risk of periodontitis remain unclear.
Methods:
We emulated target trials using US electronic health records (1995-2019) to compare the 5-year risk of incident periodontitis among adults with osteoarthritis-initiating NSAIDs versus acetaminophen. Eligible individuals had osteoarthritis, no prior periodontitis and no recent use of either medication. We estimated the risk of periodontitis using a pooled logistic regression model, adjusting for confounding via inverse probability weighting. Additionally, we conducted a subgroup analysis by NSAID COX selectivity, along with a negative control outcome analysis examining dental caries.
Results:
The 5-year risk difference (NSAIDs - acetaminophen) was 0.13% (95% CI: -0.32%, 0.58%). Similar findings were observed across subgroups compared with acetaminophen: non-selective NSAIDs, 0.11% (95% CI: -0.36%, 0.59%); preferential COX-2 NSAIDs, 0.10% (95% CI: -0.71%, 0.92%). The 5-year risk difference for dental caries was -0.27% (95% CI: -1.01%, 0.50%).
Conclusion:
We found no evidence that initiating NSAIDs, compared with acetaminophen, influenced the 5-year risk of periodontitis, and no differences by COX selectivity. Our findings align with inconclusive evidence from smaller studies on NSAIDs as adjuncts in periodontitis treatment.
